IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,980 | -26.9% | 1,534 | +13.1% | 0.00% | 0.0% |
| Q2 2023 | $9,546 | -36.7% | 1,356 | -45.1% | 0.00% | -50.0% |
| Q1 2023 | $15,092 | -26.4% | 2,470 | -23.0% | 0.00% | -33.3% |
| Q4 2022 | $20,493 | +127.7% | 3,207 | +228.9% | 0.00% | +50.0% |
| Q3 2022 | $9,000 | -18.2% | 975 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -38.9% | 1,020 | -8.0% | 0.00% | -33.3% |
| Q1 2022 | $18,000 | -14.3% | 1,109 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | +950.0% | 1,125 | +1462.5% | 0.00% | +200.0% |
| Q3 2021 | $2,000 | -33.3% | 72 | -40.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | – | 120 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | +92.9% | 1,000 | +100.0% | 0.01% | +60.0% |
| Q4 2019 | $14,000 | +100.0% | 500 | -33.3% | 0.01% | +66.7% |
| Q1 2019 | $7,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |